Mind Medicine (MindMed) Inc. (FRA:MMQ)
Germany
· Delayed Price · Currency is EUR 10.66
+0.01 (0.09%)
Last updated: Dec 5, 2025, 9:20 AM CET
Mind Medicine (MindMed) Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 19.96 | 273.74 | 99.7 | 142.14 | 133.54 | 80.09 | Upgrade
|
| Cash & Short-Term Investments | 209.07 | 273.74 | 99.7 | 142.14 | 133.54 | 80.09 | Upgrade
|
| Cash Growth | -29.20% | 174.55% | -29.86% | 6.44% | 66.73% | 1094.90% | Upgrade
|
| Prepaid Expenses | 6.78 | 7.88 | 4.17 | 3.91 | 3.68 | 1.43 | Upgrade
|
| Total Current Assets | 215.85 | 281.62 | 103.87 | 146.06 | 137.22 | 81.52 | Upgrade
|
| Goodwill | 19.92 | 19.92 | 19.92 | 19.92 | 19.92 | - | Upgrade
|
| Other Intangible Assets | - | - | 0.53 | 3.69 | 6.87 | - | Upgrade
|
| Other Long-Term Assets | 1.15 | 0.61 | 0.22 | 0.33 | - | - | Upgrade
|
| Total Assets | 236.92 | 302.15 | 124.54 | 169.99 | 164 | 81.52 | Upgrade
|
| Accounts Payable | 8.11 | 2.01 | 4.14 | 2.11 | 4.18 | 2.02 | Upgrade
|
| Accrued Expenses | 18.95 | 12.83 | 11.63 | 5.88 | 6.23 | 0.99 | Upgrade
|
| Other Current Liabilities | 38.28 | 24.01 | 16.48 | 9.9 | - | - | Upgrade
|
| Total Current Liabilities | 65.42 | 38.85 | 32.25 | 17.89 | 10.41 | 3.01 | Upgrade
|
| Long-Term Debt | 40.39 | 21.85 | 14.13 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.03 | 1.18 | 1.93 | 2.64 | Upgrade
|
| Total Liabilities | 106.32 | 60.7 | 46.41 | 19.08 | 12.34 | 5.65 | Upgrade
|
| Additional Paid-In Capital | 661.83 | 639.51 | 367.99 | 344.76 | 288.29 | 120.22 | Upgrade
|
| Retained Earnings | -532.24 | -398.88 | -290.2 | -194.47 | -137.67 | -44.64 | Upgrade
|
| Comprehensive Income & Other | 1 | 0.82 | 0.34 | 0.63 | 1.05 | 0.28 | Upgrade
|
| Shareholders' Equity | 130.6 | 241.45 | 78.13 | 150.92 | 151.66 | 75.87 | Upgrade
|
| Total Liabilities & Equity | 236.92 | 302.15 | 124.54 | 169.99 | 164 | 81.52 | Upgrade
|
| Total Debt | 40.99 | 21.85 | 14.13 | - | - | - | Upgrade
|
| Net Cash (Debt) | 168.09 | 251.89 | 85.58 | 142.14 | 133.54 | 80.09 | Upgrade
|
| Net Cash Growth | -37.97% | 194.35% | -39.80% | 6.44% | 66.73% | 1094.90% | Upgrade
|
| Net Cash Per Share | 1.98 | 3.57 | 2.19 | 4.61 | 4.88 | 4.51 | Upgrade
|
| Filing Date Shares Outstanding | 98.51 | 75.37 | 41.33 | 38.06 | 28.58 | 75.41 | Upgrade
|
| Total Common Shares Outstanding | 76.77 | 75.1 | 41.1 | 37.98 | 28.55 | 75.41 | Upgrade
|
| Working Capital | 150.43 | 242.77 | 71.63 | 128.16 | 126.81 | 78.51 | Upgrade
|
| Book Value Per Share | 1.70 | 3.21 | 1.90 | 3.97 | 5.31 | 1.01 | Upgrade
|
| Tangible Book Value | 110.68 | 221.53 | 57.69 | 127.31 | 124.88 | 75.87 | Upgrade
|
| Tangible Book Value Per Share | 1.44 | 2.95 | 1.40 | 3.35 | 4.37 | 1.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.